The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Molecular mechanisms and clinical applications of angiogenesis
Open accessAbstract
Blood vessels deliver oxygen and nutrients to every part of the body, but also nourish diseases such as cancer. Over the past decade, our understanding of the molecular mechanisms of angiogenesis (blood vessel growth) has increased at an explosive rate and has led to the approval of anti-angiogenic drugs for cancer and eye diseases. So far, hundreds of thousands of patients have benefited from blockers of the angiogenic protein vascular endothelial growth factor, but limited efficacy and resistance remain outstanding problems. Recent preclinical and clinical studies have shown new molecular targets and principles, which may provide avenues for improving the therapeutic benefit from anti-angiogenic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In clinical settings, this approach has been proven to be ineffective when used alone [23].”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [23]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to increasing drug resistance, a high SS could influence tumor cells' gene expression, comprise immune cells ability to kill cancerous cells or even turn macrophages to tumorfriendly cells, thereby enhancing the metastatic potential of cancer cells [180-184].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [184]
Experimental — accuracy not yet measuredIn the citing paper
“This disparity is, in part, attributed to VEGF-independent nonangiogenic mechanisms of vascularization (such as vessel co-option) that are exploited by cancer cells at the early stages of metastasis formation6,9,55,56”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [9]
In the citing paper
“Several cellular and molecular mechanisms of escape from antiangiogenic therapies have been postulated and investigated, including activation of alternative angiogenic pathways, recruitment of proangiogenic myeloid cells, increased pericyte cell coverage of tumour blood vessels, increased tumour cell invasion, and alternative modes of vessel recruitment7,9,80”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“Tumour vessels become abnormal in almost all aspects of their structure and functio”
BackgroundSelf-citationAngiogenesis in health and disease
Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,379
Self-citationIntegrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2748 · Cited by 3,815
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Angiogenesis in life, disease and medicine
Carmeliet, P. (2005) · Nature · doi:10.1038/nature04478 · Cited by 3,551
Self-citationVEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953 · cited 1×
“Aberrant FGF signalling promotes tumour angiogenesis and mediates the escape of tumour vascularization from VEGF- or epidermal growth factor receptor (EGFR)-inhibitor treatmen”
BackgroundMatrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Molecular regulation of vessel maturation
Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm0603-685 · Cited by 2,594
Self-citationHypoxia-inducible factors and the response to hypoxic stress
Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.022 · Cited by 2,380
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 1,021
Angiogenesis in the atherosclerotic plaque
Camaré, C., Pucelle, M., Nègre-Salvayre, A., & Salvayre, R. (2017) · Redox Biology · doi:10.1016/j.redox.2017.01.007 · Cited by 401
Coordinating cell behaviour during blood vessel formation
Geudens, I., & Gerhardt, H. (2011) · Development · doi:10.1242/dev.062323 · Cited by 403
Aydin, M. M., & Akçalı, K. C. (2018) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2018.17330 · Cited by 397
Bernardo-Castro, S., Sousa, J. A., Brás, A., Cecília, C., Rodrigues, B., Almendra, L., Machado, C., Santo, G., da Silva, F. A. D. A., Ferreira, L., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.594672 · Cited by 395
Marcel, V., Ghayad, S. E., Belin, S., Thérizols, G., Morel, A., Solano-Gonzàlez, E., Vendrell, J. A., Hacot, S., Mertani, H. C., Albaret, M. A., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.013 · Cited by 394
González-Ávila, G., Sommer, B., Mendoza-Posada, D. A., Ramos, C., García-Hernández, A. A., & Falfán‐Valencia, R. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.02.010 · Cited by 393
Mitochondrial ROS regulation of proliferating cells
Diebold, L., & Chandel, N. S. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.198 · Cited by 391
Yeung, T.-L., Leung, C. S., Yip, K., Yeung, C. L. A., Wong, S. T. C., & Mok, S. C. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00188.2015 · Cited by 384
Vascular endothelial growth factor: a neurovascular target in neurological diseases
Lange, C. M., Storkebaum, E., de Almodóvar, C. R., Dewerchin, M. A., & Carmeliet, P. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.88 · Cited by 384
Self-citationHIFs, angiogenesis, and metabolism: Elusive enemies in breast cancer
de Heer, E. C., Jalving, M., & Harris, A. L. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137552 · Cited by 372
Tumor-induced perturbations of cytokines and immune cell networks
Burkholder, B., Huang, R.-Y., Burgess, R., Luo, S., Jones, V. S., Zhang, W., Lv, Z., Gao, C., Wang, B.-L., Zhang, Y., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.01.004 · Cited by 372
Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
Gandhi, T. K. B., & Hong, W. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00049 · Cited by 363
TGF-β Signaling in Control of Cardiovascular Function
Goumans, M.-J., & ten Dijke, P. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022210 · Cited by 360
Endothelial Cell Tube Formation Assay for the In Vitro Study of Angiogenesis
DeCicco-Skinner, K. L., Henry, G. H., Cataisson, C., Tabib, T., Gwilliam, J. C., Watson, N. J., Bullwinkle, E. M., Falkenburg, L., O’Neill, R. C., Morin, A., et al. (2014) · Journal of Visualized Experiments · doi:10.3791/51312 · Cited by 360
The Link Between Angiogenesis and Endothelial Metabolism
Potente, M., & Carmeliet, P. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105134 · Cited by 360
Self-citationBronckaers, A., Hilkens, P., Martens, W., Gervois, P., Ratajczak, J., Struys, T., & Lambrichts, I. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.013 · Cited by 359
Kloepper, J., Riedemann, L., Amoozgar, Z., Seano, G., Susek, K., Yu, V., Dalvie, N., Amelung, R. L., Datta, M., Song, J. W., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525360113 · Cited by 357
Self-citationBioactive Glasses: Sprouting Angiogenesis in Tissue Engineering
Kargozar, S., Baino, F., Hamzehlou, S., Hill, R. G., & Mozafari, M. (2018) · Trends in biotechnology · doi:10.1016/j.tibtech.2017.12.003 · Cited by 354
Strategies for the discovery and development of therapies for metastatic breast cancer
Eckhardt, B. L., Francis, P. A., Parker, B. S., & Anderson, R. L. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd2372 · Cited by 353
Batchelor, T. T., Gerstner, E. R., Emblem, K. E., Duda, D. G., Kalpathy–Cramer, J., Snuderl, M., Ancukiewicz, M., Polaskova, P., Pinho, M. C., Jennings, D. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318022110 · Cited by 353
Self-citationLahm, T., Douglas, I. S., Archer, S. L., Bogaard, H. J., Chesler, N. C., Haddad, F., Hemnes, A. R., Kawut, S. M., Kline, J. A., Kolb, T. M., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201806-1160st · Cited by 353
Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease.
Goel, S., Wong, A. H.-K., & Jain, R. K. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006486 · Cited by 352
Self-citationThe Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma
Pinter, M., Jain, R. K., & Duda, D. G. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.3381 · Cited by 352
Self-citationEndothelial Cell Metabolism in Health and Disease
Rohlenová, K., Veys, K., Santos, I. M., Bock, K. D., & Carmeliet, P. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.10.010 · Cited by 351
Self-citationVasculogenic mimicry in carcinogenesis and clinical applications
Luo, Q., Wang, J., Zhao, W., Peng, Z., Liu, X., Li, B., Zhang, H., Shan, B., Zhang, C., & Duan, C. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00858-6 · Cited by 350
Lee, V. K., Lanzi, A. M., Ngo, H., Yoo, S., Vincent, P. A., & Dai, G. (2014) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-014-0340-0 · Cited by 349
Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges
Bagno, L., Hatzistergos, K. E., Balkan, W., & Hare, J. M. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.05.009 · Cited by 349
Drosophila melanogaster: A Model Organism to Study Cancer
Mirzoyan, Z., Sollazzo, M., Allocca, M., Valenza, A., Grifoni, D., & Bellosta, P. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00051 · Cited by 348
Golpanian, S., Wolf, A., Hatzistergos, K. E., & Hare, J. M. (2016) · Physiological Reviews · doi:10.1152/physrev.00019.2015 · Cited by 344
TGF-beta in CAF-mediated tumor growth and metastasis
Calon, A., Tauriello, D. V. F., & Batlle, E. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.12.008 · Cited by 342
Type-2 pericytes participate in normal and tumoral angiogenesis
Birbrair, A., Zhang, T., Wang, Z., Messi, M. L., Olson, J. D., Mintz, A., & Delbono, O. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00084.2014 · Cited by 342
Hypoxia—a key regulator of angiogenesis and inflammation in rheumatoid arthritis
Konisti, S., Kiriakidis, S., & Paleolog, E. M. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.205 · Cited by 342
Markers of Response for the Antiangiogenic Agent Bevacizumab
Lambrechts, D., Lenz, H., de Haas, S., Carmeliet, P., & Scherer, S. J. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.2762 · Cited by 341
Self-citationSignaling pathways and therapeutic interventions in gastric cancer
Lei, Z., Teng, Q., Qin, T. L., Chen, W., Xie, Y., Wu, K., Zeng, Q., Zeng, L., Pan, Y., Chen, Z., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01190-w · Cited by 338
Faecal microbiota transplantation protects against radiation‐induced toxicity
Cui, M., Xiao, H., Li, Y., Zhou, L., Zhao, S., Luo, D., Zheng, Q., Dong, J., Zhao, Y., Zhang, X., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201606932 · Cited by 340
Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials.
Liu, J., Wang, Y., Akamatsu, Y., Lee, C. C., Stetler, R. A., Lawton, M. T., & Yang, G.-Y. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.11.004 · Cited by 335
Goodson, W. H., Lowe, L. J., Carpenter, D. O., Gilbertson, M., Ali, A. M., Salsamendi, A. L. D. C., Lasfar, A., Carnero, A., Azqueta, A., Amedei, A., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv039 · Cited by 336
Mao, L., Xia, L., Chang, J., Liu, J., Jiang, L., Wu, C., & Fang, B. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.08.015 · Cited by 331
Vascularized organoids on a chip: strategies for engineering organoids with functional vasculature
Zhang, S., Wan, Z., & Kamm, R. D. (2021) · Lab on a Chip · doi:10.1039/d0lc01186j · Cited by 331
Strategies to improve the EPR effect: A mechanistic perspective and clinical translation
Ikeda-Imafuku, M., Wang, L. L.-W., Rodrigues, D., Shaha, S., Zhao, Z., & Mitragotri, S. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.043 · Cited by 330
Contribution of Angiogenesis to Inflammation and Cancer
Aguilar‐Cázares, D., Chavez-Dominguez, R., Carlos‐Reyes, Á., López‐Camarillo, C., la Cruz, O. N. H.-D., & López-González, J. S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01399 · Cited by 330
Extracellular Matrix Remodeling of Adipose Tissue in Obesity and Metabolic Diseases
Ruiz‐Ojeda, F. J., Méndez-Gutiérrez, A., Aguilera, C. M., & Plaza‐Díaz, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194888 · Cited by 334
Engineering of a functional bone organ through endochondral ossification
Scotti, C., Piccinini, E., Takizawa, H., Todorov, A., Bourgine, P. E., Papadimitropoulos, A., Barbero, A., Manz, M. G., & Martín, I. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220108110 · Cited by 328
Regulation of Endothelial Cell Differentiation and Specification
Marcelo, K. L., Goldie, L. C., & Hirschi, K. K. (2013) · Circulation Research · doi:10.1161/circresaha.113.300506 · Cited by 327
Overcoming the Limits of Hypoxia in Photodynamic Therapy: A Carbonic Anhydrase IX-Targeted Approach
Jung, H. S., Han, J., Shi, H., Koo, S., Singh, H., Kim, H.-J., Sessler, J. L., Lee, J. Y., Kim, J., & Kim, J. S. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b02396 · Cited by 326
Effect of Stromal Cells in Tumor Microenvironment on Metastasis Initiation
Guo, S., & Deng, C. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.25720 · Cited by 326
Vascular pathobiology in chronic liver disease and cirrhosis – Current status and future directions
Iwakiri, Y., Shah, V. H., & Rockey, D. C. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.05.047 · Cited by 323
Flow-Regulated Endothelial S1P Receptor-1 Signaling Sustains Vascular Development
Jung, B., Obinata, H., Galvani, S., Mendelson, K., Ding, B., Skoura, A., Kinzel, B., Brinkmann, V., Rafii, S., Evans, T., et al. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.07.015 · Cited by 322
Aggressive pituitary adenomas—diagnosis and emerging treatments
Ieva, A. D., Rotondo, F., Syro, L. V., Cusimano, M. D., & Kovács, K. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.64 · Cited by 322
Role of the tumor microenvironment in tumor progression and the clinical applications (Review)
YUAN, Y., JIANG, Y.-C., SUN, C.-K., & CHEN, Q.-M. (2016) · Oncology Reports · doi:10.3892/or.2016.4660 · Cited by 320
Extracellular regulation of VEGF: Isoforms, proteolysis, and vascular patterning
Vempati, P., Popel, A. S., & Gabhann, F. M. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.11.002 · Cited by 319
Peterson, T. E., Kirkpatrick, N. D., Huang, Y., Farrar, C. T., Marijt, K. A., Kloepper, J., Datta, M., Amoozgar, Z., Seano, G., Jung, K., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525349113 · Cited by 317
Self-citationSingle-Cell RNA Sequencing Maps Endothelial Metabolic Plasticity in Pathological Angiogenesis
Rohlenová, K., Goveia, J., García‐Caballero, M., Subramanian, A., Kalucka, J. M., Treps, L., Falkenberg, K. D., de Rooij, L. P. M. H., Zheng, Y., Lin, L., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.03.009 · Cited by 317
Self-citationExosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers
Olejarz, W., Kubiak-Tomaszewska, G., Chrzanowska, A., & Lorenc, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165840 · Cited by 299
Marino, N., Woditschka, S., Reed, L. T., Nakayama, J., Mayer, M., Wetzel, M., & Steeg, P. S. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.06.012 · Cited by 315
Opacic, T., Dencks, S., Theek, B., Piepenbrock, M., Ackermann, D., Rix, A., Lammers, T., Stickeler, E., Delorme, S., Schmitz, G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03973-8 · Cited by 315
Angiogenesis and Inflammation Crosstalk in Diabetic Retinopathy
Capitão, M., & Soares, R. A. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25575 · Cited by 314
Masiero, M., Simões, F. C., Han, H. D., Snell, C. E., Peterkin, T., Bridges, E., Mangala, L. S., Wu, S. Y., Pradeep, S., Li, D., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.06.004 · Cited by 313
Cross-Talk between NADPH Oxidase and Mitochondria: Role in ROS Signaling and Angiogenesis
Fukai, T., & Ushio‐Fukai, M. (2020) · Cells · doi:10.3390/cells9081849 · Cited by 313
Organic Dye Based Nanoparticles for Cancer Phototheranostics
Cai, Y., Si, W., Huang, W., Chen, P., Shao, J., & Dong, X. (2018) · Small · doi:10.1002/smll.201704247 · Cited by 309
Joussen, A. M., Ricci, F., Paris, L. P., Korn, C., Quezada-Ruiz, C., & Zarbin, M. A. (2021) · Eye · doi:10.1038/s41433-020-01377-x · Cited by 308
Coupling of neurogenesis and angiogenesis after ischemic stroke
Ruan, L., Wang, B. Z., Zhuge, Q., & Jin, K. (2015) · Brain Research · doi:10.1016/j.brainres.2015.02.042 · Cited by 307
Cancer imaging by optical coherence tomography: preclinical progress and clinical potential
Vakoc, B. J., Fukumura, D., Jain, R. K., & Bouma, B. E. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3235 · Cited by 307
Self-citationResponse of the cerebral vasculature following traumatic brain injury
Salehi, A., Zhang, J. H., & Obenaus, A. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17701460 · Cited by 306
Bulla, R., Tripodo, C., Rami, D., Ling, G. S., Agostinis, C., Guarnotta, C., Zorzet, S., Durigutto, P., Botto, M., & Tedesco, F. (2016) · Nature Communications · doi:10.1038/ncomms10346 · Cited by 301
ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway
Zhang, Q., Lu, S.-H., Li, T., Yu, L., Zhang, Y., Zeng, H., Qian, X., Bi, J., & Lin, Y. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1156-5 · Cited by 300
microRNAs Biogenesis, Functions and Role in Tumor Angiogenesis
Annese, T., Tamma, R., Giorgis, M. D., & Ribatti, D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.581007 · Cited by 299
Molecular Pathways: Vasculogenic Mimicry in Tumor Cells: Diagnostic and Therapeutic Implications
Kirschmann, D. A., Seftor, E. A., Hardy, K. M., Seftor, R. E. B., & Hendrix, M. J. C. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3237 · Cited by 297
An Overview of Cancer Treatment Modalities
Abbas, Z., & Rehman, S. (2018) · InTech eBooks · doi:10.5772/intechopen.76558 · Cited by 297
Castells, M., Thibault, B., Delord, J., & Couderc, B. C. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13089545 · Cited by 294
Agnihotri, S., Burrell, K. E., Wolf, A., Jalali, S., Hawkins, C. E., Rutka, J. T., & Zadeh, G. M. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0203-0 · Cited by 293
Cao, Z., Lis, R., Ginsberg, M. D., Chavez, D., Shido, K., Rabbany, S. Y., Fong, G., Sakmar, T. P., Rafii, S., & Ding, B. (2016) · Nature Medicine · doi:10.1038/nm.4035 · Cited by 293
Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells
Colwell, N. A., Larion, M., Giles, A. J., Seldomridge, A. N., Sizdahkhani, S., Gilbert, M. R., & Park, D. M. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now258 · Cited by 293
Effects of aging on angiogenesis
Lähteenvuo, J., & Rosenzweig, A. (2012) · Circulation Research · doi:10.1161/circresaha.111.246116 · Cited by 292
Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2α
Wang, Q., He, Z., Huang, M., Liu, T., Wang, Y., Xu, H., Duan, H., Ma, P., Zhang, L., Zamvil, S. S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03050-0 · Cited by 293
Unraveling the Role of Angiogenesis in Cancer Ecosystems
Zuazo-Gaztelu, I., & Casanovas, O. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00248 · Cited by 291
Current Applications of Nanoemulsions in Cancer Therapeutics
Sánchez‐López, E., Guerra, M., Dias-Ferreira, J., López-Machado, A., Ettcheto, M., Cano, A. C., Espina, M., Camins, A., García, M. L., & Souto, E. B. (2019) · Nanomaterials · doi:10.3390/nano9060821 · Cited by 287
Mitochondrial transfer mediates endothelial cell engraftment through mitophagy
Lin, R., Im, G., Luo, A. C., Zhu, Y., Hong, X., Neumeyer, J., Tang, H.-W., Perrimon, N., & Melero‐Martin, J. M. (2024) · Nature · doi:10.1038/s41586-024-07340-0 · Cited by 285
Microfluidic techniques for development of 3D vascularized tissue
Hasan, A., Paul, A., Vrana, N. E., Zhao, X., Memic, A., Hwang, Y.-S., Dokmeci, M. R., & Khademhosseini, A. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.091 · Cited by 282
Stem cells as drug delivery methods: Application of stem cell secretome for regeneration
Tran, C., & Damaser, M. S. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.007 · Cited by 281
Targeting Placental Growth Factor/Neuropilin 1 Pathway Inhibits Growth and Spread of Medulloblastoma
Snuderl, M., Batista, A., Kirkpatrick, N. D., de Almodóvar, C. R., Riedemann, L., Walsh, E. C., Anolik, R., Huang, Y., Martin, J. D., Kamoun, W. S., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.036 · Cited by 281
Self-citationThe angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential
Watt, S. M., Gullo, F., van der Garde, M., Markeson, D., Camicia, R., Khoo, C. P., & Zwaginga, J. J. (2013) · British Medical Bulletin · doi:10.1093/bmb/ldt031 · Cited by 281
BMP signaling in vascular diseases
Cai, J., Pardali, E., Sánchez‐Duffhues, G., & ten Dijke, P. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.04.030 · Cited by 280
Dønnem, T., Hu, J., Ferguson, M. L., Adighibe, O., Snell, C. E., Harris, A. L., Gatter, K. C., & Pezzella, F. (2013) · Cancer Medicine · doi:10.1002/cam4.105 · Cited by 279
Paunovska, K., Sago, C. D., Monaco, C. M., Hudson, W. H., Castro, M. G., Rudoltz, T. G., Kalathoor, S., Vanover, D. A., Santangelo, P. J., Ahmed, R., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b00432 · Cited by 277
Angiogenesis as a hallmark of solid tumors - clinical perspectives
Majidpoor, J., & Mortezaee, K. (2021) · Cellular Oncology · doi:10.1007/s13402-021-00602-3 · Cited by 276
Zhang, Y., Xie, Y., Hao, Z., Zhou, P., Wang, P., Fang, S., Lu, L., Xu, S., & Xia, Y. Q. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c22671 · Cited by 276
Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets
Zhao, Y., Xiong, W., Li, C., Zhao, R., Lu, H., Song, S., Zhou, Y., Hu, Y., Shi, B., & Ge, J. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01652-9 · Cited by 275
Engineering and physical sciences in oncology: challenges and opportunities
Mitchell, M. J., Jain, R. K., & Langer, R. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.83 · Cited by 273
Self-citationCCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis
Ehling, J., Bartneck, M., Wei, X., Gremse, F., Fech, V., Möckel, D., Baeck, C., Hittatiya, K., Eulberg, D., Luedde, T., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-306294 · Cited by 273
Funahashi, Y., Okamoto, K., Adachi, Y., Semba, T., Uesugi, M., Ozawa, Y., Tohyama, O., Uehara, T., Kimura, T., Watanabe, H., et al. (2014) · Cancer Science · doi:10.1111/cas.12488 · Cited by 273
Detterbeck, F. C., Franklin, W. A., Nicholson, A. G., Girard, N., Arenberg, D. A., Travis, W. D., Mazzone, P. J., Marom, E. M., Donington, J. S., Tanoue, L. T., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.01.025 · Cited by 273
Microenvironment and tumor cell plasticity: An easy way out
Taddei, M. L., Giannoni, E., Comito, G., & Chiarugi, P. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.042 · Cited by 272
Nanotechnology for angiogenesis: opportunities and challenges
Kargozar, S., Baino, F., Hamzehlou, S., Hamblin, M. R., & Mozafari, M. (2020) · Chemical Society Reviews · doi:10.1039/c8cs01021h · Cited by 271
Passaro, D., Tullio, A. D., Abarrategi, A., Rouault‐Pierre, K., Foster, K., Ariza‐McNaughton, L., Montaner, B., Chakravarty, P., Bhaw, L., Diana, G., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.08.001 · Cited by 270
Drug Resistance in Glioblastoma: A Mini Review
Haar, C. P., Hebbar, P., Wallace, G., Das, A., Vandergrift, W. A., Smith, J. A., Giglio, P., Patel, S. J., Ray, S. K., & Banik, N. L. (2012) · Neurochemical Research · doi:10.1007/s11064-011-0701-1 · Cited by 269
Controlling escape from angiogenesis inhibitors
Sennino, B., & McDonald, D. M. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3366 · Cited by 268
Huda, M. N., Nafiujjaman, M., Deaguero, I. G., Okonkwo, J., Hill, M. L., Kim, T. H., & Nurunnabi, M. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c00217 · Cited by 268
VEGF signaling inside vascular endothelial cells and beyond
Eichmann, A., & Simons, M. (2012) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2012.02.002 · Cited by 267
Schultheis, B. S., Strumberg, D., Santel, A., Vank, C., Gebhardt, F., Keil, O., Lange, C. M., Giese, K., Kaufmann, J., Khan, M., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.55.0376 · Cited by 267
Metadata
- Authors
- Carmeliet, P., & Jain, R. K.
- Affiliations
- Harvard University (US)
- Corresponding author
- Carmeliet, Peter
- Jain, Rakesh K.
- ORCID
- Carmeliet, Peter
- Venue
- Nature
- Published
- 2011-05
- Volume
- 473
- Issue
- 7347
- Pages
- 298-307
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4049445
- OpenAlex
- W1992112921
- Semantic Scholar
- cc1723f25e863386b91340ea03cd76a22de359ae
- Cited by
- 5,467
- References
- 100
- Citations by year
- 2026: 238 · 2025: 316 · 2024: 308 · 2023: 364 · 2022: 393 · 2021: 442 · 2020: 399 · 2019: 399 · 2018: 384 · 2017: 454 · 2016: 369 · 2015: 375 · 2014: 326 · 2013: 342 · 2012: 284
- FWCI
- 29.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (R01CA115767, R01CA085140, P01CA080124, R01CA126642, R01CA163815)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Health Sciences › Medicine › Oncology › Vascular Tumors and Angiosarcomas
- Keywords
- angiogenesis, angiogenesis inhibitors, vascular endothelial growth factor, VEGF inhibitors, drug resistance, molecular targets, cancer, eye diseases, blood vessel development
- MeSH terms
- Animals, Blood Vessels, Fibroblast Growth Factors, Humans, Platelet-Derived Growth Factor, Transforming Growth Factor beta, Neovascularization, Physiologic, Angiogenesis Inhibitors, Vesicular Transport Proteins, Vascular Endothelial Growth Factor A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
